Drug recall
Lidocaine Patch 5% (700 mg),(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC…
FDA recall event 80004 · Class III · Teva Pharmaceuticals USA
Key facts
| Event ID | 80004 |
|---|---|
| Recall numbers | D-0857-2018 |
| Recalling firm | Teva Pharmaceuticals USA |
| Product type | Drugs |
| Products | Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30) |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Failed Stability Specifications |
| Initiation date | Apr 30, 2018 |
| Report date | May 30, 2018 |
| Termination date | Jan 14, 2019 |
| City | North Wales |
| State | PA |
| Country | United States |
| FEI number | 3003092769 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: